(Press-News.org) More than 10 million people are sickened by tuberculosis (TB) globally each year, resulting in 1.5 million deaths. Yet, as many as two billion people are infected with Mycobaterium tuberculosis, the bacterium that causes tuberculosis, and are otherwise healthy and asymptomatic. Scientists who study TB look at those individuals who can tolerate and contain the infection in hopes of developing better treatments and vaccines.
The key feature of tuberculosis infection in humans is the formation of granulomas, or clusters of immune cells in the lungs that contain the infection. These granulomas contain B cells, all-purpose immune cells that perform a variety of functions, from producing antibodies to regulating the activity of other cells. For years, researchers assumed that these B cells must be performing a specific direct function in the granulomas to control TB infection, but in a new study, scientists from the University of Chicago and Washington University in St. Louis show that these B cells are actually directing reinforcements to help.
In the study, published in Nature Immunology, the team eliminated different expected B cell functions one by one in animal models of TB to narrow down the possibilities for which components prevented progression of disease. Nothing seemed to make a difference, whether removing plasma cells that produce antibodies or knocking out other B cell functions that produce immune signaling molecules.
“No matter what we knocked out individually in B cells, it didn’t make a difference. All the predicted functions that people think B cells are doing were not what they were doing in the lung for protection against TB,” said Shabaana Khader, PhD, the Bernard and Betty Roizman Professor and Chair of Microbiology at UChicago and senior author of the study. “But they needed to be there, because when we knocked TB-specific B cells out completely, you start seeing that the mice get sick. So, we knew that it wasn't any of these usual suspects.”
In addition to the results in mice, the team saw the same results when they completely deleted B cells in non-human primate models.
B cells aren’t the only immune cells present in granuloma tissue. T cells, another important white blood cell of the immune system, also play a part, specifically CD4+ or “helper” T cells that can initiate immune responses. Both B and T cells interact to control tuberculosis progression, but until this study, just how much either contributed and interacted wasn’t completely clear.
As Khader and her team narrowed down the potential functions of the B cells, they saw that the helper T cells express transcription factors that in turn generate T cell subtypes, including T follicular helper (Tfh)-like cells that localize within the granuloma tissue. It is these Tfh-like cells that activate macrophages to keep the TB infection in check by surrounding and killing infected cells, but the B cells tell them where to go and localize within the granulomas. So, instead of directly controlling TB themselves, B cells are pointing the Tfh-like cells in the right direction to do the job.
“An effective way to activate macrophages is to get Tfh-like cells to come there and activate them, and that's what the B cell is doing,” Khader said.
The only vaccine for tuberculosis was first produced in 1921, and while it’s effective in preventing some forms of childhood TB, its protection is widely variable for adults. Understanding how some people are able to control TB infection naturally could help develop better versions in the future.
“If you can initiate the protective immune response much earlier, the bacteria will never get a chance to establish infection in the lung,” Khader said. “We could make a vaccine that generates the right kind of immune response so that when you get exposed to the bacteria, you won't even carry the latent infection. So, our resolution for vaccine design is much cleaner now since we know what cell types to target in the lung.”
The study, “Antigen-specific B cells direct T follicular- like helper cells into lymphoid follicles to mediate Mycobacterium tuberculosis control,” was supported by the National Institutes of Health and Washington University in St. Louis. Additional authors include Rosemary V. Swanson, Ananya Gupta, Lan Lu, Bruce A. Rosa, Sadia Akter, Shibali Das, Mushtaq Ahmed, Ekaterina Esaulova, Maxim N. Artyomov, Jennifer Gommerman, Smriti Mehra, and Makedonka Mitreva from Washington University in St. Louis; Taylor W. Foreman from the Tulane National Primate Research Center; Jose Alberto Choreno-Parra and Joaquin Zuniga from Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico; Stanley Kimbung Mbandi and Thomas J. Scriba from the University of Cape Town, South Africa; Maria de la Luz Garcia-Hernandez and Javier Rangel-Moreno from the University of Rochester; and Dhiraj K. Singh and Deepak Kaushal from the Texas Biomedical Research Center.
END
How two different types of immune cells help two billion people keep tuberculosis in check
New research shows how B cells direct T cells to granuloma tissue in the lungs where they can activate macrophages to neutralize TB infections.
2023-04-03
ELSE PRESS RELEASES FROM THIS DATE:
Do Earth-like exoplanets have magnetic fields? Far-off radio signal is promising sign
2023-04-03
Earth's magnetic field does more than keep everyone's compass needles pointed in the same direction. It also helps preserve Earth’s sliver of life-sustaining atmosphere by deflecting high energy particles and plasma regularly blasted out of the sun. Researchers have now identified a prospective Earth-sized planet in another solar system as a prime candidate for also having a magnetic field — YZ Ceti b, a rocky planet orbiting a star about 12 light-years away from Earth.
Researchers Sebastian Pineda and Jackie Villadsen observed a repeating radio signal emanating from the star YZ Ceti using the Karl G. Jansky Very Large Array, a radio telescope ...
Higher lithium levels in drinking water may raise autism risk
2023-04-03
Pregnant women whose household tap water had higher levels of lithium had a moderately higher risk of their offspring being diagnosed with autism spectrum disorder, according to a new study led by a UCLA Health researcher.
The study, published April 3 in JAMA Pediatrics, is believed to be the first to identify naturally occurring lithium in drinking water as a possible environmental risk factor for autism.
“Any drinking water contaminants that may affect the developing human brain deserve intense scrutiny,” said lead study author Beate Ritz, MD, PhD, professor of neurology in the David Geffen School of Medicine at UCLA ...
Nasal vaccine to prevent COVID-19 passes first tests
2023-04-03
Since the beginning of the COVID-19 pandemic, researchers have been working on mucosal vaccines that can be administered through the nose. Now, scientists in Berlin have developed a live attenuated vaccine for the nose. In “Nature Microbiology”, they describe the special immune protection it induces.
Joint press release by Freie Universität Berlin, Max Delbrück Center and Charité – Universitätsmedizin Berlin
Coronaviruses spread primarily through the air. When infected people speak, cough, sneeze or laugh, they expel droplets of saliva containing the virus. Other people then breathe ...
Research finds global emissions of several banned ozone-destroying chemicals are increasing
2023-04-03
The research, published today in Nature Geoscience and led by the University of Bristol and National Oceanic and Atmospheric Administration (NOAA), puts the rise in part down to the chemicals, known as chlorofluorocarbons or CFCs, being used to make other ozone-friendly alternatives to CFCs. This is an exception allowed under the Montreal Protocol, but contrary to its wider goals.
Lead author Dr Luke Western, a Research Fellow at the University of Bristol and researcher at the NOAA’s Global Monitoring Laboratory (GML), said: “We’re paying attention to these emissions now because of the success of the Montreal Protocol. CFC ...
Early menopause, later start to hormone therapy may increase risk of Alzheimer’s disease
2023-04-03
BOSTON — Women are more likely than men to develop Alzheimer’s disease (AD), with women making up two-thirds of the population living with AD. A new study, led by Mass General Brigham researchers, sheds light on the relationship between the risk of Alzheimer’s disease and age of menopause and use of hormone therapy (HT). The results, published in JAMA Neurology, indicate that early age at menopause may be a risk factor for AD dementia, but that women who were prescribed HT around the age of menopause onset did not show increased risk.
“HT is the most reliable way to ameliorate severe menopause symptoms, ...
Comparison of postpartum opioid prescriptions before vs during pandemic
2023-04-03
About The Study: In this study of 460,000 privately insured postpartum women, patients who gave birth to a single, live newborn after March 2020 were more likely to fill more potent and more frequent opioid prescriptions than patients who gave birth prior to March 2020. Increases were larger for patients delivering via cesarean birth than those delivering vaginally. Increases in opioid prescriptions may be associated with increased risk of opioid misuse, opioid use disorder, and opioid-related overdose among postpartum women.
Authors: Shelby R. Steuart, M.P.A., of ...
Genetics of preterm birth and pregnancy length clarified
2023-04-03
New knowledge of the genetic factors behind premature delivery and gestational duration has now emerged. Findings presented by a major international study under the aegis of the University of Gothenburg include the ways in which, before birth, the woman’s and the unborn child’s genes have mutually antagonistic effects.
These results, now published in the journal Nature Genetics, enhance the potential for long-term development of drugs to induce parturition (birth) and — even more importantly — achieve the goal of preventing preterm births.
Globally, preterm (or premature) birth is the most frequent immediate cause of death among newborns and children ...
More U.S. prostate cancer patients choosing active surveillance
2023-04-03
The number of prostate cancer patients in the U.S. choosing active surveillance over surgery or radiation has rapidly increased since 2010, rising from 16% to 60% for low-risk patients and from 8% to 22% for patients with favorable intermediate-risk cancers, according to a study published today in JAMA Internal Medicine.
Active surveillance includes actively monitoring prostate cancer for progression, with the intention to intervene with surgery or radiation therapy if the cancer progresses.
It is the preferred treatment option for men with low-risk ...
Double-slit experiment that proved the wave nature of light explored in time
2023-04-03
Imperial physicists have recreated the famous double-slit experiment, which showed light behaving as particles and a wave, in time rather than space.
The experiment relies on materials that can change their optical properties in fractions of a second, which could be used in new technologies or to explore fundamental questions in physics.
The original double-slit experiment, performed in 1801 by Thomas Young at the Royal Institution, showed that light acts as a wave. Further experiments, however, showed that light actually ...
Researchers show lorlatinib is safe and effective for patients with ALK-driven relapsed/refractory high-risk neuroblastoma
2023-04-03
Philadelphia, April 3, 2023—In a significant step for the treatment of neuroblastoma, an international group of researchers led by Children’s Hospital of Philadelphia (CHOP), Winship Cancer Institute of Emory University and the New Approaches to Neuroblastoma Therapy (NANT) Consortium has shown that the targeted therapy lorlatinib is safe and effective in treating high-risk neuroblastoma. The findings, published today in Nature Medicine, have led to a major amendment in a phase 3 Children’s Oncology Group (COG) clinical trial, which has incorporated lorlatinib for newly diagnosed ALK-driven high-risk neuroblastoma, ...
LAST 30 PRESS RELEASES:
The human touch of doctors will still be needed in the AI healthcare revolution, technology expert suggests
Helping me, inhibiting you: Analysis of interactions between intestinal microbiota
Hearing loss lowers prospects of employment and higher income for young Americans
Dramatically lower temperature, same high performance!
Trigger warnings fall flat, but safe spaces build trust in the classroom
Searching for a lethal needle in a haystack: synthetic opioid 1000 times more potent than morphine
Smart wound monitor poised to improve chronic infection care
Study reveals spinning could reduce NHS waiting lists for physiotherapy treatments
New AI tool illuminates “dark side” of the human genome
CCNY team discovers potential chemo-induced cognitive changes in cancer survivors
New mRNA-based therapy that shows promise in heart regeneration after heart attack
Extremists use gaming platforms to recruit - study
Nearly 70% of U.S. children in car crashes with a fatality were not using proper child passenger restraints, study finds
Understanding what makes some bladder cancers resistant to chemotherapy
Protecting your beating heart
The key to lowering your water bill may already be at your door
Saliva testing may reveal early signs of diabetes and obesity
4D images show heat shield damage goes below the surface
Hibernator “superpowers” may lie hidden in human DNA
Changes in diet drove physical evolution in early humans
Experts call for science- and evidence-based AI policy
Challenges in governing rapidly emerging marine-climate interventions
Slowdown in protein translation drives aging in the killifish brain
Behavior drives morphological change during primate evolution
Climate interventions to save our oceans need stronger governance, experts warn
Do you want to freeze a cloud? Desert dust might help
Nanodevice uses sound to sculpt light, paving the way for better displays and imaging
Twinkle, twinkle leopard seal: songs below the ice flow like nursery rhymes
Potato evolved from tomato 9 million years ago
MIT researchers show how the brain distinguishes 'things' from 'stuff'
[Press-News.org] How two different types of immune cells help two billion people keep tuberculosis in checkNew research shows how B cells direct T cells to granuloma tissue in the lungs where they can activate macrophages to neutralize TB infections.